Results 31 to 40 of about 58,702 (314)

In Vitro Release of Interferon-Gamma from Peripheral Blood Lymphocytes in Cutaneous Adverse Drug Reactions

open access: yesClinical and Developmental Immunology, 2012
Background. Cutaneous drug reactions are common but diagnostically challenging due to phenotypic heterogeneity and simultaneous exposure to multiple drugs. These limitations prompted the development of diagnostic tests. Aims.
Ilan Goldberg   +4 more
doaj   +1 more source

Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. [PDF]

open access: yesPLoS ONE, 2010
The measurement of Interferon gamma or Interferon gamma inducible protein (IP)-10 in antigen stimulated blood samples is suggested as an alternative method for latent tuberculosis (TB) diagnosis.
Basirudeen Syed Ahamed Kabeer   +4 more
doaj   +1 more source

Dynamic changes of interferon-gamma Release Assay results along with latent tuberculosis infection treatment.

open access: yesClinical Microbiology and Infection, 2020
OBJECTIVES Using QuantiFERON-TB Gold In-Tube (QFT-GIT) for monitoring tuberculosis (TB) and latent TB infection (LTBI) treatment effect is controversial. The present study aims to evaluate the dynamic changes of interferon gamma (IFN-γ) levels along with
H. Xin   +17 more
semanticscholar   +1 more source

T-SPOT. TB assay and tuberculin skin test for diagnosis and screening of tuberculosis: First report in a Sri lankan population

open access: yesAsian Journal of Medical Sciences, 2015
Objective: Guidelines encourage evaluation of an Interferon Gamma Release Assay (IGRA) in the local setting, particularly in low/ middle income, Bacillus Calmette Guerin (BCG) vaccinated populations where the assays have shown variable utility. The TSPOT.
Champa N Ratnatunga
doaj   +1 more source

Agreement between the results of tuberculin skin test and Interferon-Gamma Release Assays in renal transplant candidates

open access: yesJournal of Research in Medical Sciences, 2021
Introduction: Identification of latent tuberculosis (TB) infection is important in kidney transplant candidates. Due to the absence of a gold standard, both tuberculin skin test (TST) and interferon-gamma release assays (IGRA) are used to screen patients.
Shiva Samavat   +8 more
doaj   +1 more source

Tuberculin skin test and interferon‐γ release assays: Can they agree?

open access: yesThe Clinical Respiratory Journal, 2023
Introduction The diagnosis of latent tuberculosis infection (LTBI) relies largely on the tuberculin skin test (TST) or, more recently, on interferon‐gamma release assays (IGRA).
João Almeida Santos   +2 more
doaj   +1 more source

The Tuberculin Skin Test Increases the Responses Measured by T Cell Interferon‐Gamma Release Assays [PDF]

open access: yesScandinavian Journal of Immunology, 2008
AbstractRUTI is a vaccine consisting of Mycobacterium tuberculosis bacilli grown in stress conditions that is fragmented, detoxified and liposomed. RUTI was designed to shorten the treatment of latent tuberculosis infection (LTBI) with isoniazid from 9 months to just 1 month, by additional treatment with two inoculations of RUTI 4 weeks apart.
Vilaplana, C   +8 more
openaire   +3 more sources

Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis

open access: yesThe Indian journal of medical research, 2015
Background & objectives: Tuberculosis (TB) is a common infection in patients on haemodialysis. There is a definite role of treatment of latent TB (LTB) in these patients.
S. Agarwal   +4 more
semanticscholar   +1 more source

Tuberculosis control in the Republic of Korea [PDF]

open access: yesEpidemiology and Health, 2018
The incidence and mortality rates of tuberculosis (TB) in the Republic of Korea are 77 and 5.2 per 100,000 people, respectively (2016), which are the highest among the member countries of the Organization for Economic Cooperation and Development ...
Kyung Sook Cho
doaj   +1 more source

Evaluation of a commercial interferon-γ release assay for the detection of SARS-CoV-2 T-cell response after vaccination

open access: yesHeliyon, 2023
Objective: Evidence regarding the role of cellular immunity in protecting against COVID-19 is emerging. To better assess immune status, simple and robust assays measuring specific T-cell responses associated with humoral responses are needed. We aimed to
Imane Saad Albichr   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy